Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin

NCT00467051 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00467051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00467051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
November 5, 2007
Completion date
June 30, 2018
Enrollment
20 (actual)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

childhood extracranial germ cell tumor, childhood extragonadal malignant germ cell tumor, childhood malignant ovarian germ cell tumor, childhood malignant testicular germ cell tumor, ovarian choriocarcinoma, ovarian embryonal carcinoma, ovarian yolk sac tumor, recurrent childhood malignant germ cell tumor, recurrent malignant testicular germ cell tumor, recurrent ovarian germ cell tumor, testicular choriocarcinoma, testicular embryonal carcinoma, testicular mixed choriocarcinoma and embryonal carcinoma, testicular mixed choriocarcinoma and yolk sac tumor, testicular mixed embryonal carcinoma and yolk sac tumor, testicular yolk sac tumor